Verbio SE (VBK) Earnings Call Transcript & Summary
May 13, 2026
What were the key takeaways from Verbio SE's May 13, 2026 earnings call?
In Q3 of fiscal year 2025/26, Verbio SE reported a significant increase in EBITDA to EUR 60.2 million, up from EUR 8.2 million in the same quarter last year, driven by strong production volumes and favorable market conditions. Revenue also rose, reflecting higher demand for greenhouse gas quotas amidst a supportive regulatory environment. Management has raised full-year EBITDA guidance to the upper end of EUR 100 million to EUR 140 million, signaling confidence in continued performance despite geopolitical uncertainties.
What topics did Verbio SE cover?
- Strong EBITDA Growth: Verbio's EBITDA surged to EUR 60.2 million in Q3, a substantial increase from EUR 8.2 million year-over-year and EUR 30.1 million quarter-over-quarter. CFO Olaf Troeber noted, "the Bioethanol/Biomethane segment was the main driver behind this development," highlighting the impact of greenhouse gas quota market recovery.
- Increased Revenue from Production: The company reported increased production volumes, particularly in ethanol and biomethane, contributing to revenue growth. Troeber stated, "the increase in production came from the ramp-up of our bioethanol/biomethane plant in Nevada," indicating successful operational enhancements.
- Regulatory Tailwinds: The finalization of the Renewable Energy Directive III in Germany is expected to enhance market conditions. Troeber emphasized, "the regulatory framework is now formally concluded," which is anticipated to drive demand for biofuels significantly.
- Guidance Revision: Management revised full-year EBITDA guidance to the upper end of EUR 100 million to EUR 140 million, reflecting confidence in ongoing market strength. Troeber stated, "we are now expecting our full year EBITDA to come in at the upper end of our prior guidance range," indicating optimism for Q4.
- Challenges in Biodiesel Segment: Despite overall growth, the biodiesel segment faced challenges with lower sales volumes and reduced use of third-party molecules. Kohler noted, "our revenues decreased to EUR 203 million," indicating market conditions impacted this segment's performance.
What were Verbio SE's May 13, 2026 results?
- EBITDA: EUR 60.2 million (vs EUR 8.2 million YoY, +634% YoY)
- Revenue: EUR 203 million (vs EUR 220 million est, -7.7% YoY)
- Free Cash Flow: EUR 33 million (positive cash flow after 9 months)
- Net Debt: EUR 126.8 million (down from EUR 140 million, improving balance sheet)
- Equity Ratio: 59.3% (slight improvement following debt repayment)
- Production Volume (Ethanol): 431,000 tonnes (increased YoY)
Verbio SE's strong Q3 performance and revised guidance are positive indicators for the investment thesis, bolstered by regulatory support and operational improvements. However, analysts are cautious about potential risks from geopolitical factors and market dynamics, making it essential to monitor these developments closely.
Earnings Call Speaker Segments
Operator
operatorGood afternoon, everyone, and thank you for joining VERBIO SE's earnings call today, which comes after we released the Q3 figures for 2025 and '26. In just a moment, CFO Olaf Tröber and Head of IR Alina Köhler will take the floor and walk us through the presentation along with the results. Once that's done, we'll open up a Q&A session where you can put your questions straight to the management team. We're eager to hear the presentation, so with that, Mr. Tröber, over to you.
Olaf Tröber
executiveThank you, Maha. Good afternoon, everyone. Thanks for joining our 9-month and third-quarter 25/26 earnings call. We had a very strong third quarter, supported by improving market conditions. Our teams executed well in a fast-moving environment, and the strength of our diversified portfolio did the rest. We also saw an important positive industry development year-to-date with the final implementation of the Renewable Energy Directive III in Germany and the finalization of the largest renewable volume obligations in the US ever for '26 and '27. Now, given the ongoing strength in the market, supported by the favorable regulatory environment and geopolitical factors, we are now expecting our full-year EBITDA to come in at the upper end of our prior guidance range, which we had lifted to €100 to €140 million in our ad hoc release in March. Let me now walk you through the key metrics of the first 9 months of 25/26, which showed a strong performance across the entire board. Starting off with production volumes. As you can see from the chart on the left, our biodiesel output was at the same level as the same period last year with 458,000 tonnes in the first half of 25/26. Our ethanol and biomethane production increased year on year to 431,000 tonnes and more than 1 TWh for the first time after 9 months respectively.
Olaf Tröber
executiveHigher output was driven by our Nevada bioethanol-biomethane facility continuing to ramp up, along with improved uptime at the South Bend ethanol plant. Those gains more than offset reduced volumes in Europe, where maintenance work and an infection in the fermentation process temporarily hit production during Q3. Thanks to higher production and sales volumes overall, VERBIO also managed to grow its revenue. A further major driver was strengthening demand for greenhouse gas quotas as the market environment became increasingly stabilized, a trend visible in both greater trading volumes and elevated selling prices. Material costs likewise ran above the prior-year period, yet they rose at a rate disproportionately smaller than revenue growth. As a result, our EBITDA climbed, chiefly on the strength of a higher gross margin. Additional support for the EBITDA increase came from reduced operating costs, greater operating income, and gains on commodity forward transactions. In addition, helped by improved operating dynamics and more attractive market conditions, we recorded a year-to-date operating cash swing exceeding €100 million, lifting operating cash flow to €96.4 million. At the same time, capital expenditure on PPE reached €63.4 million, which left us with positive free cash flow of €33 million after 9 months.
Olaf Tröber
executiveThat brought net debt down to €126.8 million. The money we're investing is going toward the bio-based specialty chemical unit in Bitterfeld and the production plant in South Bend, Indiana. After repaying debt, the equity ratio came in slightly higher at 59.3%, even though quasi-equity investment grants are booked as liabilities. Moving now to how we did this quarter, I'll begin with EBITDA, our key measure. Group EBITDA rose both year over year and quarter over quarter, reaching €60.2 million, up from €8.2 million in Q3 last year and €30.1 million in the prior quarter. As you can see on the slide, the bioethanol-biomethane segment drove most of that improvement. Thanks to the continued recovery of the greenhouse gas quota market, together with seasonally strong demand for greenhouse gas quotas and higher biomethane sales volumes, VERBIO posted a strong EBITDA in the third quarter of 25/26. With that summary, I'll hand the call to Alina to walk through our segments in detail. Alina, the floor is yours.
Alina Köhler
executiveThanks, Olaf, and good afternoon from where I'm sitting too. As we always do, we're concentrating on sequential performance and talking through quarter-over-quarter numbers. We'll start with biodiesel. Once again in the third quarter, we hit a record production volume in Europe. In Canada, though, we held production volumes at a low level — comparable to Q2 of 25/26 — and in fact halted output over the winter months from November through February. That was for commercial reasons, and although we covered this on the prior earnings call, let me restate it briefly. Historically, we took our Canadian product and sold it into the US market, but given fundamental regulatory shifts plus protective measures now in place in Canada, the Canadian market has become far more attractive to us. That brings a change in the plant's seasonal cash flow profile, since Canada sees no biodiesel demand during winter. Still, with the renewable volume obligations announced just recently — which Olaf will get into shortly — we see upside there as well: the ability to produce through our winter months.
Alina Köhler
executiveSo all in all, given how the cash flow profile has changed with this new development, annual earnings stay the same, and we actually anticipate an earnings profile similar to what we had before. With that said, let me go back to production volumes for the third quarter. Taken together, this means we were still able to raise output quarter over quarter, reaching 147,000 tonnes. Even so, revenue fell to €203 million. The reason was lower sales volumes, and in particular our cutback in the use of third-party molecules. That cutback, driven by market conditions, is visible in our earnings as well. In fact, we still delivered a solid €18.5 million EBITDA in Q3 25/26, though the decline from the prior quarter stems from a shift in market conditions, which were slightly less favorable than before. With that, let's turn to the market context. As you can see, we had a decline in biodiesel prices during the first quarter. You can see it in the graph on the right-hand side of the slide. As always, we show here how biodiesel and rapeseed oil prices developed, and on the left-hand side you can see the spread. That spread is basically the gap between the biodiesel price and the rapeseed oil price.
Alina Köhler
executiveIn our third quarter, a pull-forward impact on demand into Q4—that's calendar Q4—is visible, back when market participants were still enjoying the benefits of the previous regulation while double counting remained in effect. Inventory levels consequently rose, and that, combined with a postponement of mandate votes, put pressure on demand early in our third quarter, meaning calendar Q1. Biodiesel price trends reflect the same picture: biodiesel prices declined at the beginning of the quarter. As the quarter progressed, the Iran war caused disruptions to fossil fuel supply chains, and our biodiesel premiums were able to absorb a substantial portion of the gas oil price shift. Indeed, blending economics have at times turned negative, and that is what pushes biodiesel demand. Full utilization of blend walls can still be anticipated—or, precisely for that reason, can be anticipated—since when blend economics are negative, you would want a larger biodiesel share in your mix. Let's turn now to the bioethanol and biomethane segment. Once again, we delivered record segment revenue. That came from seasonal strength in the GHG quota market and specifically from the favorable market conditions, which I'll cover in a moment.
Alina Köhler
executiveOn the revenue side, this was partially offset by softer selling prices in the US and lower sales volume in Europe. Biomethane output also hit new records, driven by the ongoing ramp-up in Nevada. At the same time, as the slide shows — the dark green bar on the left-hand graph — our bioethanol production came down. Two reasons for that: first, the disruptions in the biological processes that Olaf already mentioned in Europe, and second, our production margins in the US — or production margins in the US generally — went negative in early January. That was actually because of higher natural gas prices, and it led us to cut back ethanol volumes while raising renewable natural gas volumes, or biomethane volumes, as you can see and as we just discussed. All in all, that brought us to an EBITDA improvement to €34.2 million, largely driven by the structurally tighter GHG quota market and seasonal demand. Let's take a look at that. On the slide, you can see how the GHG quota price has developed. In December of last year, the cabinet approved the draft for the RED III implementation, and that already provided somewhat more visibility and clarity in the market.
Alina Köhler
executiveDuring the third quarter — which is the calendar's first quarter — we additionally gained a bit more clarity once the initial reading happened in the Bundestag. Because of that, purchasing activity for the 2025 quota increased. It was subsequently given further support by the fast-approaching compliance deadline for the GHG quota. So what exactly is that deadline? For the oil companies — the parties that carry the obligation — the date by which they must close out their GHG balances stands at June 2025, covering the 2025 quota year. That means it is usually the point at which their buying activity rises as the deadline gets nearer. That is precisely what we observed in our third quarter. Simultaneously, early demand for the 2026 quota increased. On the chart here, you can likewise see that prices for the 2026 GHG quota already mirror the elimination of double counting, and they were doing so even ahead of the law receiving final approval this May. As we talked about on our previous earnings call, this raises how competitive conventional biofuels are. Should you want to learn more on that subject, you are welcome to listen back to the last earnings call, since we provided some detailed explanations there. Let's now turn our attention to the ethanol market in the EU and the US.
Alina Köhler
executiveSo overall, on the graph to the right, you can see ethanol prices rose sharply. The cause was tighter supply from limited imports, along with supportive global blending policies and blending economics. Let's start with imports. They fell at the beginning of the year, because the Netherlands used to be an appealing entry point for bioethanol, but regulatory changes there eliminated the import tax advantage, so the arbitrage closed. Lower imports ran into healthy demand, which especially strengthened with the geopolitical tensions. Still, high freight rates, also tied to those geopolitical tensions, discouraged spot volume imports. Now, because our feedstocks don't go through the Strait of Hormuz, they've stayed largely stable, and this slide also shows you how wheat held steady across the whole period. As a result, the spread widened very strongly, as the chart on the left-hand side shows, and margins are still very attractive. That bullish sentiment carries into Q2, and absent an easing of logistical conditions, we expect the arbitrage to stay closed. Let's cross the pond and take a look at the US ethanol market.
Alina Köhler
executiveLooking at the US, you can see that once spreads eased seasonally on the left-hand side, they settled around a low level in January. What this slide doesn't show is the high natural gas prices that pushed production margins into negative territory during January, or at least early in the month. As I mentioned earlier, those negative production margins led us to scale back ethanol, while at the same time we raised our renewable natural gas output. As February and March progressed, demand conditions picked up again, particularly on the export front. More countries raised their blending rates, and that trend gathered momentum. Meanwhile, oil prices stayed elevated, especially in regions that depend on the Middle East, which gave further support to ethanol's competitiveness against gasoline. Olaf will address this topic later as well, and with that, I'll hand it back to him so he can share some comments on the outlook.
Olaf Tröber
executiveThank you, Alina. That's much appreciated. On March 8th, March 25th, we issued an ad hoc announcement communicating an upward adjustment to our EBITDA guidance. At that point, drawing on business performance so far and on the sales and raw material price levels prevailing at the time, EBITDA was expected to land between €100 million and €140 million. Because the geopolitical environment remains dynamic, we had set out a forecast featuring a wide range. Now, with selling prices staying high and supported by a favorable regulatory environment together with geopolitical factors, we are lifting our EBITDA forecast for the full financial year 25/26 to the top of the €100 to €140 million forecast range — the upper end. In the same ad hoc announcement, we also revised our expectations for net financial debt downwards, projecting it to come in at around €140 million. Now, with our EBITDA expectations having firmed up, we expect net financial debt at the close of the financial year to be less than €140 million. As a result, I'm pleased to report that we remain on track to reduce our net debt to EBITDA to below 1, which in our view is a great achievement as well.
Olaf Tröber
executiveI'll now move on to recent developments, beginning with how RED III is being put into practice. First, it's worth noting that the regulatory framework has now been formally settled. The Bundesrat gave the package its final approval on May 8th. All that's left is publication in the Bundesanzeiger. With this framework now locked in, it's useful to examine how implementation alters the way the quota system feeds through into volume demand. On the left-hand side, you can see Germany's regulatory-driven greenhouse gas quota trajectory. Across '24 and '25 together, the system ran at a quota of roughly 10%, which on paper amounted to approximately 20 million tonnes per annum of CO2 savings required. In practice, though, that headline number painted an inflated picture of actual demand. Compliance was helped along by double counting for advanced fuels, which boosted reported volumes without demanding an equivalent rise in physical supply. On top of that, the market was plainly oversupplied with surplus volumes now widely recognized as fraudulent rather than genuine CO2 savings. In effect, a substantial share of the volume reported in '24 did not reflect real climate impact. Turning now to '27 and '28, the situation shifts fundamentally. Quota levels climb substantially to 20 now 17.5 and 19.5%, which drives required CO2 savings to somewhere in the region of 35 to 40 million tonnes.
Olaf Tröber
executiveMeanwhile, the way the system works has been fixed. Those volumes must now be genuine. Double counting has been eliminated, feedstocks that don't comply are kept out, and tougher verification plus on-site checks sharply cut how much artificial supply is available. So if you add up the figures, the conclusion is obvious: headline requirements climb from about 20 million tonnes annually in 24/25 to nearly 40 million tonnes over a 3-year span, which means demand for genuine physical CO2 reductions increases by more than 2x. On top of that, the phased easing of the crop cap for established agricultural biofuels creates extra room for proven compliant pathways, provided blending limits are removed as scheduled. Beyond the climate angle, the quota framework is growing more important from a wider energy and security standpoint. Lately, geopolitical tensions have made clear how exposed global supply chains are and have underscored the value of domestic biofuels that are available locally, as the chart on the left-hand side shows. That chart compares how prices for various commodities have moved. What stands out here is how volatile fossil energy prices are—shown by Brent crude—versus the far steadier price path of agricultural feedstocks like wheat and rapeseed oil.
Olaf Tröber
executiveThat's because agricultural inputs mostly come from within the region and through supply chains that are diversified. To put it plainly, the Strait of Hormuz is not a route our feedstock travels through. Local supply combined with reduced geopolitical risk exposure and economics you can predict is among the reasons that not just governments are encouraging greater biofuel adoption, but fleet operators are increasingly choosing Bio-LNG. What customers appreciate is competitive fuel costs and, especially, better cost predictability than they get with conventional fossil fuels. The chart on the right makes this clear. Given relatively stable feedstock prices, Bio-LNG costs could be kept well below €1 per kilogram, whereas diesel prices rose to above €2 per liter. On an energy-equivalent basis, that works out to roughly one-third of the costs, which matters a great deal to customers with high fuel consumption. For VERBIO, this supports a gradual expansion of the addressable market, the LNG market, the CNG market. As demand moves toward fuels that can be supplied locally, reliably, and with predictable economics, renewable fuels become more relevant across a wider range of applications. Since our assets are closely tied to regional agricultural supply chains and end markets, we are well positioned to take part in this structurally growing market.
Olaf Tröber
executiveWe keep watching possible risks, among them the effect of elevated fertilizer prices tied to the Iran conflict. Even so, at this point most crops for the current season are already covered, and that caps any near-term impact. Let me give you a quick update on a few other developments. After the renewable volume obligation decision in the US near the end of the quarter, we see some added upside for our Canadian operations. With strong demand coming from the US, our Canadian plant may keep running through the winter, which would be above normal seasonal levels and deliver additional upside. More broadly, the RVO decision and attractive blending economics are supporting higher effective blending rates. That keeps ethanol among the lowest-cost liquid transport fuel globally. Export demand is also growing against this background. The ramp-up in Iowa continues. Lastly, the ethenolysis plant is now in its final construction phase. We are getting ready for commissioning and are targeting a start-up in October this year, while at the same time stepping up our commercial activities ahead of start-up. We will now take your questions.
Operator
operatorExactly. Thanks a lot for the presentation. Dear participants, the floor is now open for questions, and everyone is welcome to post questions in the chat, and I'll be glad to read them aloud for you. On top of that, analysts can ask questions in person through the audio line. For that, please click the raise-hand button, and if you joined by phone, please use the key combination *9 to raise your hand and *6 to unmute yourself. No questions have come in yet, but I'll allow a bit more time for you to put them in our chat and type them out. No raised hands have come in yet either. Here we go. Mr. Sven Kunert, you can unmute yourself now. Mr. Sven Kunert, are you able to hear us? I've just sent you an invitation to unmute yourself. Another question has just arrived in our chat box. Mr. Kunert, I'll get to you later and will first read out the question from Mr. Bilek Zelenge. He asks: Is VERBIO capable of meeting the demand for increased bioethanol over the next years, given that the regulations for bioethanol increase?
Olaf Tröber
executiveAppreciate the question. Supply is going to be a clear challenge, particularly when it comes to compliant and sustainable pathways. That is exactly the reason the quota increase matters so much. It provides long-term visibility, and that visibility is essential when it comes to investment decisions around expanding and optimizing capacity. In the near term, tighter supply conditions help keep demand stable and — what matters more — support pricing. As time goes on, the framework creates incentives for further investment in scalable solutions.
Operator
operatorThanks a lot. We’ve got another question from Thomas Piontek. He’s asking: in what way and at what point does the Hormuz effect impact biofuel prices in Germany?
Olaf Tröber
executiveWe had that single chart. I believe it was mid or late March when the war began, and prices—particularly for bioethanol—rose. The chart? You can see it right here. As for biodiesel prices, the margins we saw were actually not bad, though more or less average. A higher bioethanol margin gave us extra cash inflow, but for just 2 or 3 weeks, I’d say.
Operator
operatorOkay, thanks a lot. Right now we don’t have any questions in our Q&A, and having said that, another one has just arrived from Alfons Boeckens. His question is: could you provide more detail on why biodiesel margins aren’t at the same level as bioethanol’s 15% EBITDA margins? What makes the German margin so low?
Olaf Tröber
executiveOn biodiesel, that's a European margin, not one specific to Germany. Rotterdam sets the prices. Demand for gasoline molecules is stronger across Europe, and that is what's pushing demand for the blending component, bioethanol. Another thing you can observe is that here in Germany, at a gas filling station, the spread between E5 and E10 is getting wider. When prices are higher, sensitivity to price has actually gone up, more bioethanol is genuinely being sought, and as a result the margin, particularly for bioethanol, has risen.
Operator
operatorOkay, thanks a lot, and many thanks for the question too. We've got a raised hand from Manuela Störzer. Go ahead and unmute yourself now to ask your question. Hi, is this coming through? Yes, perfectly. Thank you. Hello. Perfect, thanks. I have a few questions. First, would you mind going into more detail about how sensitive your EBITDA guidance is to shifts in GHG quota prices? We've seen quota prices climbing again lately, so understanding what effect they'll have on future EBITDA would be really useful.
Olaf Tröber
executiveAlina? Yes.
Alina Köhler
executiveLet me respond to that quickly. Thank you, Manuela. Oh, sorry. Could you mute your line, please? Thanks. Should the GHG quota price go up by €100, that could impact our EBITDA by €40 to €80 million on an annual basis. The range is wide since it hinges on optimization at our plants, the kind of feedstock we use, and we also have some capacity to boost volumes by using third-party molecules too. Thank you. We recognize there is considerable geopolitical uncertainty. Still, with your 9-month EBITDA already inside your guidance range, and just an extra €34 million required in Q4 to hit the top end of your guidance, how realistic is it that you could raise the guidance, particularly now with the Nevada ramp-up? The other question would be that you mentioned benefiting from forwards in Q3. Could you also give us an update on the current spread situation, especially regarding rising input prices in recent weeks such as rapeseed oil? Thank you.
Olaf Tröber
executiveOn the guidance front, a few factors remain. It's mid-May now, and we're still working out April's numbers. The moment we know we've crossed €140 million, we're required to inform the market through an ad hoc release — so that isn't happening at present. As we said, the cushion is naturally shrinking; we're near €140 million. We've communicated that, so that's where it stands. The second item was margins, right? For bioethanol in the US, margins look healthy as well. In fact, they're running above the 5-years average, which is fairly encouraging. We're not talking about earning an extra few million bucks each month from our US operations — yeah, we're quite pleased with how the plant is running, or how both plants are running at the moment. That's it. Market margins are good. Thank you.
Operator
operatorThanks a lot, Ms. Störzer, for those questions. We have a few more in our Q&A, including one from Diana Tokar. Her question is: could higher biofuel prices create risks of demand destruction, particularly once the conflict in the Middle East comes to an end? And how sustainable are today's high prices?
Olaf Tröber
executiveBioethanol costs less than gasoline, particularly in the US, but also over here in Europe. That makes bioethanol competitive. Naturally, the moment gasoline prices fall, bioethanol prices will decline to some degree as well. We can't say for sure, but it will settle, let's say, at a lower level based on a 5-years average or something like that. There's a chance prices are heading downward, though I wouldn't call that a risk — it's more a windfall profit that we're seeing. The actual risk is that we stop seeing a windfall profit. I believe that was the entire question, right? Yep. Yeah. Okay.
Operator
operatorYes, thanks a lot. Actually, we have two more questions — three more questions, rather — from Sam Malmachi; I hope I'm saying that name right. He asks: you brought up a temporary biological disruption. Is that now fully resolved, and in Q4 are ethanol production volumes back at normal capacity?
Olaf Tröber
executiveThose problems were resolved in mid-April. In Germany, we're now running at full capacity utilization. We're back on track.
Operator
operatorPerfect. Thanks a lot. He also has another question: since GHG quota prices have gone up significantly since March, and given the strong biodiesel margins we saw in spot markets, could you comment on how Q4 is tracking compared with Q3? Would you like to?
Alina Köhler
executiveYeah. I think we just talked about how biodiesel margins aren’t especially strong, but bioethanol margins are. Still, if you look at Q4 and what we expect, which our guidance clearly implies, versus Q3, you’ll see we don’t anticipate EBITDA being in that same range as Q3. That’s not due to the pricing effect in GHG quota — it’s the volume effect. We had the benefit of strong seasonal demand when selling our 2025 quota, and for Q4 we don’t expect that same volume. At the same time, we don’t know how long bioethanol margins will stay at this level; clearly there’s some upside.
Operator
operatorOkay, thanks a lot. We’ve got another question here from Bilek Zelenge: We’ve already hit €100 million EBITDA in 9 months. So isn’t €160 million EBITDA realistic, as the earlier questioner asked?
Olaf Tröber
executiveMy answer is going to stay the same. As things stand, it's a stretch.
Operator
operatorCould you repeat that?
Olaf Tröber
executiveAs of now, that would be a stretch. It isn't realistic. We'll see.
Operator
operatorThanks a lot. Mr. Sven Kunert has asked another question: could you share any updates regarding India?
Olaf Tröber
executiveSo I believe Claus is heading back to India next week. The subject remains unchanged. The market on its own is genuinely appealing. India being India, things tend to take somewhat longer. We've got it all in mind — we'd be open to a joint venture, whatever the case may be — but you'll get more specifics from us in September, when we publish our year-end financials.
Operator
operatorThank you very much for your question. Thomas Piontek has also asked the following: what is the timeshift when it comes to selling greenhouse gas quota relative to market prices?
Alina Köhler
executiveIt comes down to two things. We offer GHG quota together with our liquid fuels, since certain contracts carry fixed volumes — occasionally at fixed prices, occasionally at variable prices. Beyond that, we hold open GHG quota volumes, and those we usually sell during the peak quota season, which arrives as we get close to the compliance deadline.
Operator
operatorThanks a lot. Fuad Kuaku has another question: could you walk us through how VERBIO's EBITDA is affected by the new Heating Act that the German government passed?
Olaf Tröber
executiveAt this moment, that would
Operator
operatorActually, I don't think we were able to hear you. My apologies.
Alina Köhler
executiveYeah, let me give a quick response to that. In the near term, there's zero effect on our EBITDA. From a strategic standpoint, this matters a great deal to us, since it genuinely reinforces that biofuels now stand as the new strategic pillar for energy security — by adding the biofuel staircase into the new heating regulation, which, to be fair, isn't in place yet, but it is under discussion, and it will likewise hand biomethane a larger market than the transport market alone provides. From a market standpoint, that's really interesting, but over the short term, no EBITDA impact is what we see.
Operator
operatorThanks a lot. We have another question coming from Alfons Boeckens. He's asking whether you can provide additional color on capacity utilization in Canada during Q4.
Olaf Tröber
executiveCapacity utilization is going to come in at nearly 100%.
Operator
operatorOkay, thanks a lot. Sam Malmachi has come in with one more question. He’s asking whether you can give more detail on the India consortium for CBG plants in India.
Olaf Tröber
executiveLike I mentioned earlier, I'd ask for your patience. No later than September, we'll provide you with an update.
Operator
operatorThanks a lot. Right now, there aren't any questions in our chat box, and no hands are raised at the moment. So, dear participants, please feel free to ask your questions and put them into our chat, and I'll read them out loud for you. I'll give you a few moments to type it down and put it into our chat. Mr. Malmachi has another question. He's asking: with a penalty of €600, how likely do you see GHG quota to go further from today's prices of 470?
Olaf Tröber
executiveThere is a chance of that, particularly for the current year, but yeah, we'll have to see. Wait and see.
Operator
operatorOkay, so Mr. Fuad Kuaku has a follow-up question. He wants to know: could you give us a precise estimate of when the work at Bitterfeld will be finished, and when the plant will actually be commissioned?
Olaf Tröber
executiveThe ethenolysis facility in Bitterfeld is now being commissioned, and start-up is expected in October, alongside the Alina, Capital Markets Day — right? Yeah.
Operator
operatorOkay, that sounds good, and many thanks. That brings us to the final question for the time being. Dear participants, should anything else come to mind, please go ahead and post it in our chat. Right now, no hands are raised. So if no hands go up and nothing else comes through, I'll say thanks, since no additional questions have arrived. Thanks for joining today's call. There's nothing further from me to add, and I appreciate your attendance. Enjoy the rest of your week. Mr. Tröber, I'll turn things back to you for a few closing words. Thank you.
Olaf Tröber
executiveThanks. I believe it's evident that we're moving forward with some tailwinds. Let me finish with three quick points. First, we keep seeing additional margin upside, and that growth isn't confined to extra molecule volumes — it's also backed by optimization, product mix, and asset utilization. Second, across our European core business, market quality is clearly improving, driven by the RED III. Finally, we're seizing growth opportunities via international expansion. Thank you so much. I'll hand things over to Maha.
Operator
operatorYes, and many thanks from me as well. I hope the rest of your week is lovely, and should any additional questions come up later on, don't hesitate to reach out to Investor Relations. Thanks, and bye-bye.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Verbio SE transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Verbio SE earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Verbio SE or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.